Switch to:
Apache Corporation (NYSE:APA)
Net Issuance of Stock
$-2,011 Mil (TTM As of Jun. 2014)

A company may raise cash from issuing new shares. It can also use cash to buy back shares.

Warning Sign:

Apache Corporation bought back shares. However, its track record of buying back shares is poor as the stock is now traded at -26% below its average buyback price.

Apache Corporation's net issuance of stock for the three months ended in Jun. 2014 was $-779 Mil. The number is negative, which means that Apache Corporation has paid more cash to buy back shares than it has received for issuing shares quarterly.

Apache Corporation's net issuance of stock for the trailing twelve months (TTM) ended in Jun. 2014 was $-2,011 Mil.


Definition

A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Apache Corporation Net Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2014 was 0 (Sep. 2013 ) + -748 (Dec. 2013 ) + -484 (Mar. 2014 ) + -779 (Jun. 2014 ) = $-2,011 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Cash from Financing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Apache Corporation Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Net Issuance of Stock 3425-1354436282,32800-997

Apache Corporation Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Net Issuance of Stock 217000-2490-748-484-779
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK